BCAB vs WFC · $5.9M cap vs P/E 15, $272.05B cap
Bioatla Inc (BCAB) versus Wells Fargo & Company (WFC) — a side-by-side from cached financials, not a winner call.
Bioatla Inc (BCAB) is a biotechnology company listed on NASDAQ.
Wells Fargo & Company (WFC) is a banks - diversified company listed on US. It is led by Charlie Scharf.
Latest reported BCAB revenue for 2023-09-30 was $0. Net income was -$33.3M. BCAB currently screens at market cap $5.9M.
WFC does not have a complete income-statement cache yet.
BCAB currently screens at market cap $5.9M. WFC currently screens at market cap $272.05B and trailing P/E 15.0.
Not investment advice. Open the BCAB and WFC stock pages for the full models.
Not investment advice.